
4.00 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 1.88 Today|||52-Week Range 4.70 | +57.17% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Neoleukin Therapeutics Inc have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a +87.50% increase from the last price of 4.00.
The current consensus among 1 polled investment analysts is to Hold stock in Neoleukin Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.